E mbolization during percutaneous coronary intervention in acute ST-segment-elevation myocardial infarction is frequent and may result in obstruction of the microvessel network and decreased efficacy of reperfusion and myocardial salvage. 1 Removal of atherothrombotic material before infarct artery stenting is a rational approach, and interventional approaches to thrombus-containing lesions include manual thrombus aspiration (MTA), mechanical thrombectomy by different techniques, and the use of antiembolic protection devices. The latter have not been shown to be beneficial, whereas the results of studies using MTA or mechanical thrombectomy devices are conflicting. Meta-analytic overviews of these studies showed a clinical benefit of MTA, and guidelines recommend as a reasonable approach (class IIA, level of evidence B) the use of manual aspiration catheters. 2-9 However, manual aspiration catheters are completely ineffective in ≈30% of cases, and the high profile of the devices limits their use in tortuous and calcified vessels. 10 Among the available mechanical thrombectomy techniques, the rheolytic thrombectomy (RT) device has the potential for improved thrombus removal in acute myocardial infarction (AMI) as compared with MTA. RT is accomplished with high velocity saline jets that are contained within the distal catheter tip. The device has a lower profile as compared with MTA catheters and is effective also in complex anatomy, including calcified and tortuous vessels and giant thrombuscontaining lesions. A recent randomized study, involving 501 patients and comparing RT plus direct infarct artery stenting with direct infarct artery stenting alone showed that the device could cross the occlusion without predilation in 94% of cases, and that randomization to RT was associated with a clinical benefit. 11
Intracoronary optical coherence tomography (OCT) allows the identification of coronary thrombus with higher sensitivity than angiography or intravascular ultrasound.
The aim of this randomized study was the comparison of the efficacy of MTA with RT in patients with AMI with the use of OCT for the assessment of residual thrombus after thrombectomy.
Methods

Study Design
The Comparison of Manual Aspiration with RT (SMART) trial is a randomized, 2-arm, prospective study in patients with ST-segment elevation AMI treated with primary percutaneous coronary intervention. The study was registered with ClinicalTrials.gov.
Patients
All patients with ST-segment elevation AMI were considered eligible for the study without restriction based on age or clinical status on presentation. Thus, patients with cardiogenic shock were eligible for the study. Diagnosis of AMI included (1) chest pain persisting >30 minutes and <6 hours; and (2) ST-segment elevation >1 mm in ≥2 contiguous leads or presumably new left bundle-branch block. Clinical exclusion criteria were (1) thrombolysis for the current AMI; (2) major surgery <6 weeks; (3) stroke <30 days, or any history of hemorrhagic stroke; (4) comorbidities with expected survival <1 year; and (5) participation in another study. The angiographic exclusion criteria were (1) extreme tortuosity of the infarct vessel preventing OCT assessment; (2) infarct artery reference vessel diameter <2.5 mm on visual assessment; and (3) previous stented infarct artery. Evidence of massive coronary thrombus, diffuse disease, a major branch involved in the culprit lesion, calcification, left main disease, and moderate vessel tortuousness were not considered as exclusion criteria to enrollment.
Patients were randomly assigned to MTA or RT after baseline angiography, and 1:1 randomization was performed by a computergenerated sequence.
The study was approved by the institutional ethics committee and patients or legal representatives signed written informed consent.
Treatment
RT was performed with the 4Fr XMI AngioJet catheter system (Medrad Interventional/Possis, Minneapolis, MN), and MTA with the 6Fr Export Aspiration catheter (Medtronic, Minneapolis, MN). Details of these devices and techniques were previously described. 10, 11 In all patients, after the restoration of anterograde flow, intracoronary nitrates were given to ensure maximal epicardial vessel dilation, to determine the size and length of the stent, and to facilitate stent placement. The number of passes with the RT catheter or the manual aspiration catheter was at operator's discretion, and multiple passes were allowed before OCT, whereas repeat thrombectomy was not allowed after OCT or infarct artery stenting.
Direct stenting had to be attempted in all cases. The stent used was the Promus Element (Boston Scientific, Minneapolis, MN). Pressure deployment and expansion were at the discretion of the operator according to the characteristics of the stent and lesion. Multiple inflations were discouraged. If the stent failed to cross the lesion directly, predilation was performed using an undersized balloon to decrease
WHAT IS KNOWN
• There are evidence-based guidelines for the use of manual thrombus aspiration before infarct-related artery stenting.
• Rheolytic thrombectomy device has the potential for improved thrombus removal.
WHAT THIS STUDY ADDS
• Manual thrombus aspiration or rheolytic thrombectomy results in only incomplete removal of thrombus in patients with acute myocardial infarction.
• Rheolytic thrombectomy as compared with manual aspiration was more effective in thrombus removal and in achieving myocardial reperfusion.
Optical coherence tomography (OCT) thrombus analysis. A, Consecutive cross-sectional images with evaluation of thrombus by the number of quadrants. All slices containing a thrombus are evaluated and summed; for example, in this cases the total score is 22 (3+3+4+4+4+4=22). B, A longitudinal image of this case. C, The slice containing maximum thrombus area. If the outline of thrombus is visible, the slice with maximum thrombus is chosen and analyzed by subtracting the lumen area from the area of the outline of the thrombus (C′). D, A longitudinal image of another case. E′ and F′, Measurements corresponding to E and F. If the outline of a thrombus is not visible (as it was in C), the minimum lumen area (MLA) within the thrombus (F) is chosen; and the maximum thrombus area is calculated by subtracting the MLA from the visible lumen area (not including thrombus) at the closest adjacent reference site (E′ and F′).
the risk of embolism before stent implantation. Post dilation with noncompliant balloons was at the discretion of the operator. Adjunctive pharmacological treatment during the procedure included (1) Abciximab (ReoPro, Centocor, Malvern, PA) unless contraindicated, immediately before or during the procedure as a bolus of 0.25 mg/kg of body weight followed by a 12-hour infusion at a rate of 0.125 µg/kg per minute; (2) nonfractioned heparin as an initial bolus of 70 U/kg, and additional boluses during the procedure to achieve an activated clotting time of 200 to 300 s. Heparin was discontinued at the end of the percutaneous coronary intervention procedure; and (3) aspirin (325 mg). Immediately after the procedure, patients received 60 mg of prasugrel. After the procedure, patients were routinely treated with aspirin (100 mg/d indefinitely) and prasugrel (5 or 10 mg daily for 12 months), in accordance with standard and recommended practice. Postdischarge therapy also included β-blockers, ACE-inhibitors, statins, and other drugs, according to the American College of Cardiology/American Heart Association guidelines for the treatment of myocardial infarction. 9
OCT Images Acquisition and Analysis
The culprit coronary artery was cannulated with an appropriate guiding catheter without side holes. Iodixanol 320 (Visipaque, GE Healt Care, Cork, Ireland) was injected manually via the guiding catheter at a speed of 2 to 3 mL/s during continuous electrocardiographic monitoring. The C7 OCT Imaging System (LightLab Imaging, Inc, Westford, MA) was used for OCT image acquisition (20 frames/s) during a 20-mm/s image-wire pull-back speed. A second acquisition was repeated after 3 minutes. The acquisition run with the best image quality was used for the off-line analysis. Analysis of the culprit lesion containing the ruptured plaque and thrombus included all slices to evaluate the thrombus and was performed by an independent Core Laboratory with operators blinded of treatment allocation. Each slice was subdivided into 4 quadrants, and the presence or absence of thrombus tabulated per quadrant. Thrombus was defined as intraluminal tissue >0.25 mm in diameter. The thrombus was defined either highly backscattering with high attenuation (red cell rich thrombus), less backscattering, and homogeneous with low attenuation (platelet rich thrombus), or mixture of both. 12 The total number of quadrants containing thrombus was summed. The maximum thrombus area was calculated by (1) tracing the outline of the thrombus if the outline was visible or (2) subtracting the minimum lumen area within the thrombus from the adjacent reference lumen area not having thrombus, if the outline of thrombus was not visible (Figure 1 ).
Follow-up OCT analyses included stent strut classification defined as (1) covered embedded, covered by tissue with smooth surface; (2) covered nonembedded, covered by tissue, but extending into the lumen; (3) uncovered, no visible tissue; and (4) malapposed, the strut having a distance between the middle of the strut blooming artifact and the surface of the adjacent plaque >thickness of stent strut and polymer. Malapposed struts could be covered embedded, covered nonembedded, or uncovered. 12, 13 The analysis was performed every 1 mm of the entire stent, as well as proximal and distal references 5 mm in length. Lumen, stent, and neointimal areas (stent minus lumen) were contoured every 1 mm; and total volumes were calculated using Simpson rule.
Interobserver and intraobserver variability of OCT measurements were tested using intraclass correlation and a value >0.9 was defined as excellent correlation.
Follow-up
All patients were scheduled for clinical follow-up at 1, 6, and 12 months. All other possible information derived from hospital readmission, or by the referring physician, relatives, or municipality live registries were entered into the prospective database. The protocol included coronary angiography and OCT of the infarct vessel at 6 months. Unscheduled angiography was allowed on the basis of clinical indication.
End Points
The study was designed to test the hypothesis that RT before direct stenting as compared with MTA would result in more complete thrombus removal and improved myocardial reperfusion. Moreover, the more complete removal of thrombus by RT, allowing a better estimate of the diameter and length of the target lesion, could result in the use of stents with the most appropriate size and least early malapposition.
The primary end point of the study was the amount of residual thrombus after thrombectomy as assessed by OCT. Residual thrombus was defined as the number of quadrants containing thrombus.
The secondary end points were (1) residual angiographic thrombus grade after thrombectomy and before infarct artery stenting. Angiographic assessment of thrombus was based on the thrombolysis in myocardial infarction (TIMI) thrombus grading 14 ; (2) angiographic markers of reperfusion: TIMI flow grade and TIMI myocardial blush as previously described. 15, 16 Angiographic markers of reperfusion and quantitative coronary angiography analysis were performed by physicians noninvolved in the study (ARCARD Foundation, Florence, Italy); (3) early ST-segment elevation resolution. Early ST-segment resolution was defined as a reduction in ST-segment elevation ≥50% at 30 minutes after infarct artery recanalization. 17 The ST-segment elevation resolution was assessed by 3 physicians blinded to treatment assignment; (4) procedural angiographic complications that included angiographic no-reflow, coronary perforation, and dissection; (5) percent of malapposed stent struts at 6-month OCT follow-up; (6) six-month binary angiographic restenosis (>50%); and (7) sixmonth major adverse cardiovascular events that included cardiac death, reinfarction, target vessel revascularization (TVR), and stroke. Reinfarction was defined as recurrent chest pain with ST-segment or T-wave changes and recurrent elevation of cardiac enzymes. TVR was defined as coronary angioplasty or coronary surgery performed of the target lesion of the infarct artery. Stroke was defined as an acute neurological defect lasting >24 hours.
Major bleeding was defined according to the TIMI criteria. 18
Statistical Analysis
The study was powered to demonstrate a reduction of the number of quadrants containing thrombus. We assumed that the mean value of number of thrombus-containing quadrants will be 55±20 in patients of MTA group, and 40±20 in patients of the RT group, which corresponds to an ≈25% reduction of vessel quadrants with thrombus with RT. 
Results
Patient enrollment began in October 2010 and ended in September 2011, and 80 patients were randomized to RT or MTA before infarct artery stenting. Figure 2 shows the flow-chart of the patient screening. Table 1 summarizes the baseline clinical and angiographic characteristics. The 2 groups were well matched in all characteristics, and most patients had a thrombus grade 5 at baseline angiography (mean, 4.27±1.01 in the RT group and 4.20±1.04 in the MTA group; P=0.745). Table 2 summarizes the procedural characteristics and acute angiographic results. In all patients randomized to RT the device could directly cross the occlusion, whereas in 3 patients randomized to MTA (8%) the catheter could not cross directly the occlusion. One patient of the MTA group with a residual giant thrombus after aspiration crossed over to RT, whereas no patient of the RT group crossed over to There was a trend toward higher rate of early ST-segment elevation resolution in the RT arm as compared with the MTA arm (92% and 77%, respectively; P=0.060). Table 3 shows the OCT findings after thrombectomy. The quality of OCT examinations allowed the predefined assessments in all but 4 patients (2 for each arm).
All but 1 patient had residual thrombus after thrombectomy. The number of quadrants containing thrombus was lower in the RT arm than in MTA arm, but this difference did not reach significance (median value 53 and 65, respectively; P=0.083). However, the percentage of patients with a higher residual thrombotic burden (number of quadrants containing thrombus over the median value) was significantly lower in the RT arm as compared with MTA arm (37% and 60%, respectively; P=0.039).
Angiographic evidence of thrombus was present in only 55% of patients with residual thrombus demonstrated by OCT.
Interobserver and intraobserver variability showed excellent correlation for total quadrants of thrombus (intraclass correlation; inter=0.986, intra=0.992) and maximum thrombus area (intraclass coefficient; inter=0.956, intra=0.955). Table 4 shows the 6-month clinical and angiographic outcomes. There were no differences between groups in death, myocardial infarction, or stroke, whereas TVR was more frequent in the MTA group than in the RT group. All but 1 patient underwent reintervention for in-stent restenosis. All patients with restenosis had an OCT minimum lumen area <3 mm 2 . Three patients had effort angina and evidence of ischemia on exercise test (1 in the RT arm and 2 in the MTA arm), whereas 6 patients (1 in the RT arm and 5 in the MTA arm) were asymptomatic and had a fractional flow reserve <0.80. One asymptomatic patient underwent reintervention because of severe stent strut malapposition (>1 mm). The difference in TVR rate drove the significant difference in the composite of major adverse cardiovascular event (7.5% versus 25%; P=0.034). There was a trend toward a higher >50% in-segment restenosis rate in the MTA group as compared with the RT group (21% and 7%, respectively; P=0.099).
Of the 73 eligible patients, the 6-month OCT examination was performed in 60 patients (82%). OCT was not performed in 13 patients because of patients' refusal (7 patients) and renal insufficiency (6 patients). The quality of examinations allowed the analysis in 52 patients (87%; Table 5 ). The percentage of malapposed struts was higher in the MTA group as compared with the RT group (2.7±4.5% and 0.8±1.6%, respectively; P=0.019), whereas there was no difference in the number of uncovered struts.
Discussion
The main findings of this study can be summarized as follows: (1) complete removal of thrombus by MTA or RT in the setting of AMI is not possible; (2) the surrogate primary end point of the study was not met, and only a strong trend in favor of RT could be revealed; (3) large residual thrombus was revealed more frequently in the MTA arm; (4) RT was associated with increased reduction of angiographic thrombus grade as compared with MTA, although angiography missed the residual thrombus in most cases in both groups; (5) angiographic markers of effective reperfusion were more frequently associated with RT than MTA; and (6) RT was associated with a lower percentage of malapposed struts at 6 months as compared with MTA.
After MTA or RT, OCT revealed residual thrombus in all but 1 patient. OCT demonstrated that complete thrombus removal was not possible with current techniques, and that the potential for embolization after coronary stenting may be eventually only decreased by thrombectomy. This finding can explain, at least in part, the conflicting results of previous studies using manual aspiration thrombectomy or RT. 10, 11, [19] [20] [21] [22] The study did not met the primary end point; the number of quadrants containing thrombus was lower in the RT arm as compared with MTA arm, but this difference did not reach statistical significance. However, large residual thrombus, defined as the number of quadrants containing thrombus greater than the median value was more frequent in the manual aspiration arm. This finding suggests that RT may be more effective than manual aspiration but at a lesser degree than hypothesized, or alternatively that the sum of quadrants with thrombus is weakly correlated with the volume of residual thrombus. However, the calculation of thrombus volume by OCT is impossible because of the uncertain definition of the border between the disrupted atherosclerotic plaque and the superimposed thrombus, as well as the optical shadowing of the red thrombus. Moreover, it should be remembered that this is the first study that used OCT to assess the efficacy of MTA and RT in the setting of AMI, and that our definition of the primary end point was exploratory because no previous studies used this technique to assess thrombus volume.
Conversely, the superiority of RT over MTA was revealed in all angiographic surrogate end points with a lower residual TIMI thrombus grade and higher rate of TIMI grade flow 3 and TIMI blush grade 3 after RT. Again, there was a strong trend toward more frequent early ST-segment elevation resolution, that is a validated marker of effective reperfusion, in the RT arm.
With regard to the 6-month outcome, there was no difference in major adverse cardiovascular event rate, but TVR was more frequent in the MTA arm. However, it should be remembered that the study was not powered for clinical events. The finding of less stent strut malapposition at 6 months in the RT arm suggests that the more complete removal of thrombus achieved by RT could allow a better stent strut apposition. However, the clinical relevance of this finding is unknown.
Study Limitations
The analysis and interpretation of the end point results should be considered only hypothesis generating because the primary end point of the study was not met. Because of the impossibility to calculate the true thrombus volume, we used the number of quadrants per slice containing residual thrombus and the median value of the number of quadrants with thrombus to dichotomize large thrombus and nonlarge thrombus. However, this approach that is commonly used and accepted for bivariate analyses of continuous or categorical variables can be potentially inaccurate and should be validated by further studies. The angiographic follow-up rate was higher in the MTA arm and this finding could have some impact on the higher TVR rate in the MTA arm. The comparison between MTA and RT was done with the Export catheter, and it is unknown whether newer aspiration catheters may perform better than the Export catheter. Finally, the study was powered for the primary end point (residual thrombus burden). Thus, all differences between groups in the other end points should be interpreted with caution.
Conclusions
MTA or RT allows only incomplete removal of thrombus in patients with AMI. The primary end point of the study was not met. However, RT as compared with manual aspiration seems to be more effective in thrombus removal and in myocardial reperfusion.
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